Oklahoma City, OK 73105
For Immediate Release: February 22, 2013
Senate approves Safe Compounding Act
The state Senate on Tuesday approved legislation that will require
out-of-state compounding pharmacies that deliver, dispense, or distribute
prescription drugs in Oklahoma to submit an affidavit and pharmacy
site inspection form to receive a license.
Sen. Rob Standridge, author of Senate Bill 522, said the legislation
was authored to prevent the sort of tragedy that occurred last year
when a Massachusetts pharmacy was linked to more than 300 fungal
meningitis infections and 23 deaths. The Boston Globe subsequently
reported that just 4 of 37 specialty pharmacies passed surprise
health inspections following the incident.
“This legislation is an important regulatory step to provide
patients and the public with greater protection against potential
tragedy,” said Standridge, R-Norman. “Under this legislation,
the Board will have the ability to oversee pharmacies in other states
that may not operate by the same stringent standards that ours do.
These requirements will assure compliance and safety – a good
thing for consumers and the public.”
SB 522 will only apply to out-of-state sterile compounding pharmacies.
Such pharmacies provide compounded medications not available from
pharmaceutical drug companies.
“Our Board of Pharmacy and all our pharmacy owners should
be applauded for operating at the highest standards, particularly
in sterile compounding,” Standridge said. “This measure
gives our Board the ability to assure that out-of-state pharmacies
are held to the same standard.”
Approved by a vote of 42-0, SB 522 now advances to the House for
For more information, contact:
Sen. Standridge: (405) 521-5535